Project Grant R35GM156391

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $415K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
South Dakota, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded Boston University Medical Campus a $694,875 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859). The grant will support research to understand the molecular mechanisms that impart plasticity to G protein-coupled receptor (GPCR) and G protein signaling, which has broad implications for biology and medicine. The research will focus on two main areas: 1) defining the physiological implications...
This $445,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports innovative computational research to investigate the structural basis and allosteric mechanisms governing G protein-coupled receptor (GPCR) function and coupling selectivity to G proteins. The key research projects include: Dissecting the structural role of the GPCR intracellular loop 3 (ICL3) in regulating GPCR-G...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $534,160 to support research on the molecular mechanisms underlying protein function. The key focus areas include: Elucidating the mechanisms by which ion transport proteins, such as TMEM175, CLC, IP3Rs, and CLN7, recognize and transport ions across cellular membranes, as well as how their activities are regulated. Investigating...
The National Institute of General Medical Sciences (NIGMS) awarded a $432,422 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Maine System (UMS) to conduct research on the spatiotemporal control of regulator of G-protein signaling (RGS) proteins. The project aims to examine how dynamic RGS interactions with receptors and cellular structures impact the sensitivity and spatial regulation of G-protein coupled receptor (GPCR) signaling...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $303,024 to Biocognon LLC to develop an innovative combinatorial nanobody discovery platform targeting G-protein coupled receptors (GPCRs). The project aims to establish a robust system for assembling GPCR/nanobody libraries, build a synthetic nanobody library targeting the ADRB1 and ADRB2 GPCRs, and implement a...
This federal Project Grant award, R35GM155350, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $379,131 award aims to address key biological questions on how macromolecule conformation, particularly the degree of disorder, impacts binding to "undruggable" protein surfaces and cell permeability. The project will establish colorimetric and fluorimetric assays to rapidly assess...
The National Institute of General Medical Sciences (NIGMS) awarded a $743,818 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Georgia Tech Research Corporation. The award, which runs from August 1, 2024 to July 31, 2029, supports research to identify the fundamental biochemical mechanisms underlying lipid metabolism and the role of membrane proteins in metabolizing lipids and lipid-like xenobiotics such as cannabinoids. Key objectives include...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $347,615 to Purdue University to conduct research on the mechanisms underlying the regulation of phospholipase C beta (PLCB) enzymes by heterotrimeric G proteins. The research aims to reveal new mechanistic insights into PLCB regulation and identify regulatory features unique to each PLCB isoform that could be targeted by...
This $409,375 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research on ligand-gated ion channels (LGICs) at The Johns Hopkins University. The research aims to uncover the mechanisms of how LGICs gate, how their function is regulated by auxiliary proteins, and how therapeutics impact LGIC activity. The project will focus specifically on AMPA receptors, a subtype of LGIC that...
This federal Project Grant award of $1,245,000.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will establish a high-throughput, generalizable quantitative structural cell biology platform to study dense core secretory granule (DCSG) maturation. The award, which runs from July 1, 2024 to April 30, 2029, will leverage soft X-ray tomography (SXT) and fluorescence lifetime imaging microscopy (FLIM) to map cell...

This Project Grant award for $415,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will fund research to elucidate the structure and function of G protein-coupled receptors (GPCRs) and their complex signaling capabilities. The research aims to bridge gaps in the understanding of GPCR functionality, exploring their ability to activate a wide range of G proteins across different subfamilies. By combining bioinformatics and a novel enzymological approach in living cells, the project will provide quantitative insights into GPCR-G protein selectivity and the structural underpinnings of these specific protein interactions. The findings from this foundational study are expected to transform the comprehension of GPCR involvement in physiological activities and lay the groundwork for advancing basic scientific research and developing innovative pharmacological methods. The award period runs from July 1, 2025 to June 30, 2030.

Generated 6/24/25, 4:03 AM